RISK OF EARLY AND LATE CARDIOTOXICITY IN DOXORUBICIN-TREATED BREAST-CANCER PATIENTS

被引：0
|
作者：
BUZDAR, A [1 ]
SMITH, T [1 ]
MARCUS, C [1 ]
BLUMENSCHEIN, G [1 ]
机构：
[1] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,HOUSTON,TX 77030
来源：
BREAST CANCER RESEARCH AND TREATMENT | 1983年 / 3卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：320 / 320
页数：1
相关论文
共 50 条
  • [21] Global longitudinal strain: an early marker for cardiotoxicity in patients treated for breast cancer
    van der Linde, D.
    van Hagen, I
    Veen, K.
    Zuetenhorst, H.
    van Dalen, B.
    NETHERLANDS HEART JOURNAL, 2023, 31 (03) : 103 - 108
  • [22] Global longitudinal strain: an early marker for cardiotoxicity in patients treated for breast cancer
    D. van der Linde
    I. van Hagen
    K. Veen
    H. Zuetenhorst
    B. van Dalen
    Netherlands Heart Journal, 2023, 31 : 103 - 108
  • [23] SERIAL ECHOCARDIOGRAPHY FOR EARLY DIAGNOSIS OF CARDIOTOXICITY IN BREAST CANCER PATIENTS TREATED WITH TRASTUZUMAB
    Shah, F.
    Silverman, D.
    Doloto, P.
    Micetich, K. C.
    Barron, J. T.
    CARDIOLOGY, 2014, 128 : 417 - 417
  • [24] Cardiotoxicity and pharmacogenetics of doxorubicin in black Zimbabwean breast cancer patients
    Nyangwara, Vincent Aketch
    Mazhindu, Tinashe
    Chikwambi, Zedias
    Masimirembwa, Collen
    Campbell, Thomas B.
    Borok, Margaret
    Ndlovu, Ntokozo
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 90 (08) : 1782 - 1789
  • [25] Role of neutrophils in the early presymptomatic stages of doxorubicin cardiotoxicity in breast cancer
    Todorova, Valentina K.
    Beggs, Marjorie L.
    Siegel, Eric R.
    Makhoul, Issam
    Wei, Jeanne
    Klimberg, V. Suzanne
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (28)
  • [26] MITOMYCIN AND TAMOXIFEN VERSUS MITOLACTOL, DOXORUBICIN, AND TAMOXIFEN IN PATIENTS WITH PREVIOUSLY TREATED BREAST-CANCER
    FALKSON, G
    GELMAN, RS
    TORMEY, DC
    TAYLOR, SG
    FALKSON, HC
    CANCER TREATMENT REPORTS, 1985, 69 (7-8): : 755 - 760
  • [27] PROSPECTIVE COMPARISON OF EPIRUBICIN AND DOXORUBICIN IN PREVIOUSLY-TREATED PATIENTS WITH ADVANCED BREAST-CANCER
    YOUNG, C
    WITTES, R
    JAIN, K
    GELLER, N
    CASPER, E
    INVESTIGATIONAL NEW DRUGS, 1984, 2 (01) : 100 - 100
  • [28] RISK OF BREAST-CANCER TO RELATIVES OF YOUNG BREAST-CANCER PATIENTS
    SCHWARTZ, AG
    KING, MC
    BELLE, SH
    SATARIANO, WA
    SWANSON, GM
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1985, 75 (04): : 665 - 668
  • [29] BREAST-CANCER - PATIENTS AT RISK
    LEIS, HP
    CANCER DETECTION AND PREVENTION, 1976, 1 (02): : 311 - 330
  • [30] Targeting the embryonic morphogen Nodal reduces viability of doxorubicin-treated breast cancer cells in vitro
    Bodenstine, Thomas M.
    Chandler, Grace S.
    Margaryan, Naira V.
    Strizzi, Luigi
    Gilgur, Alina
    Seftor, Elisabeth A.
    Seftor, Richard E. B.
    Khalkhali-Ellis, Zhila
    Ugolkov, Andrey
    Mazar, Andrew P.
    Hendrix, Mary J. C.
    CANCER RESEARCH, 2015, 75
12345